US Patent Issued to Arrowhead Pharmaceuticals on Feb. 17 for "RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use" (Wisconsin, California, Illinois Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,569, issued on Feb. 17, was assigned to Arrowhead Pharmaceuticals Inc. (Pasadena, Calif.).

"RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use" was invented by Phillip Lazzara (Madison, Wis.), Ji Young Suk (San Diego), Christine Esau (San Diego), Tao Pei (Middleton, Wis.), Xiaokai Li (San Diego), Agnieszka Glebocka (Madison, Wis.), Zhao Xu (San Diego), Jeffrey Carlson (Madison, Wis.), Jingdong Ye (Lincolnshire, Ill.) and Kayalvizhi Madhivanan (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are RNAi agents, compositions that include RNAi agents, and methods ...